Market open

Bioventus/$BVS

14:30

22:10

05:45

13:25

21:00

1D1W1MYTD1Y5YMAX

About Bioventus

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Ticker

$BVS

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Equipment & Supplies

Headquarters

Durham, United States

Employees

1,030

Website

www.bioventus.com

Bioventus Metrics

BasicAdvanced

$580M

-

-$0.62

0.85 -

Price and volume

Market cap

$580M

Beta

0.85

52-week high

$13.48

52-week low

$3.90

Average daily volume

301K

Financial strength

Current ratio

1.412

Quick ratio

0.78

Long term debt to equity

194.07

Total debt to equity

216.809

Interest coverage (TTM)

0.78%

Management effectiveness

Return on assets (TTM)

2.48%

Return on equity (TTM)

-24.76%

Valuation

Price to revenue (TTM)

1.022

Price to book

3.9

Price to tangible book (TTM)

-2.12

Price to free cash flow (TTM)

20.018

Growth

Revenue change (TTM)

10.40%

Earnings per share change (TTM)

-78.86%

3-year revenue growth (CAGR)

11.63%

3-year earnings per share growth (CAGR)

79.79%

What the Analysts think about Bioventus

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Bioventus stock.

Bioventus Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Bioventus Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Bioventus News

AllArticlesVideos

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

GlobeNewsWire·2 weeks ago

Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Bioventus Reports Third Quarter Financial Results

GlobeNewsWire·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BVS

$

Capital at risk

Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Bioventus stock?

Bioventus (BVS) has a market cap of $580M as of January 15, 2025.

What is the P/E ratio for Bioventus stock?

The price to earnings (P/E) ratio for Bioventus (BVS) stock is 0 as of January 15, 2025.

Does Bioventus stock pay dividends?

No, Bioventus (BVS) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next Bioventus dividend payment date?

Bioventus (BVS) stock does not pay dividends to its shareholders.

What is the beta indicator for Bioventus?

Bioventus (BVS) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.